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E D I T O R I A L
MOVEMENT DISORDERS CARE IN PAKISTAN
Nadir A Syed
Consultant Neurologist, South City Hospital, Karachi.
Earlier discussions about a professional society relating to movement disorders took place about a decade ago and were 
felt to be a little premature. However PSN nominated Dr Nadir Ali Syed to promote movement disorders related activities. 
Dr Nadir worked with patients to form a patient centered body, the Pakistan Parkinson's Society which has been quite 
active in the last several years. Some of the various Parkinson's and movement disorders related activities are listed in 
appendix A. This is an incomplete list as there is no national professional body dedicated to collate, promote and 
collaborate in movement disorders activities. The intention is to establish a national Parkinson and Movement Disorders 
Society (PMDS), a professional body, drawing upon the precedent of other professional domain specific societies 
previously established focusing on headache, epilepsy, stroke etc. If suitable to PSN the society would work under the 
PSN patronage and collaboration. The society would comprise of interested physicians, ancillary heath care workers, 
students, patients and caregivers in different classes of membership. PMDS may facilitate activities in three major 
areaswith modifications as per input of members. Education and professional development. This includes general 
public awareness, ancillary health care providers (e.g. nurses, rehab personnel), Medical students, general practitioners, 
Neurology trainees, neurologists, Rehabilitation specialists and neurosurgeons. Clinical Service. Promoting Movement 
disorders clinics, developing specialized services relevant to movement disorders. Use of information technology to reach 
out to relatively remote practitioners. Research. Promoting highlighting  and facilitating research. Strategies for achieving 
objectives would evolve with input from members but may include;
• Information technology
• Could include developing a repository of online teaching materials, modules, linkages to other websites etc. 
• Regular conferences, meeting, workshops
• Patient support groups
• Media
• Development of guidelines/protocols
• Collaboration with other national and international bodiese.g. Pakistan Parkinson's Society, a patient based society
 active largely in Karachi
On November 29th at the business meeting of PSN in Lahore it was decided to initiate a national movement disorders 
society aimed at physicians at the March 2016 meeting of PSN. PSN initiatives related to movement disorders. 
Movement disorders related activities in the previous few years - an incomplete compilation but perhaps adequate to 
demonstrate there is activity enough to providescope for a national professional body.
• October 3-4, 2015 Pakistan's first National Parkinson's and Movement Disorders Conference was held at Hotel
 Margala, Islamabad. Organized by Dr Arsalan Ahmed
• Jan 2015, 'National Guidelines for Diagnosis and Management of Parkinson's Disease' published in PJNS,  as a
 collaborative effort of national and international neurologists compiled by Dr Wasay. Subsequently published in a 
 booklet for mass dissemination to GPs. Lead author Dr Nadir Ali Syed
• 28th March 2014 Botox workshop organized as part of PSN meeting by Dr Wasay in Sheraton, Karachi  with 
 international experts including Dr Ronald Pfeiffer, Eric Wolters, and Daniel Truong
• MINDS Symposium- Movement disorders Workshop incorporated. well attended May 17-19, 2009 Muzaffarabad in
 collaboration with GSK. symposium
• Botox Workshops by Dr Nadir Ali Syed in Karachi, Islamabad and Colombo in association with Allergan. Dr Arsalan 
 has organized several botox workshops in Islamabad. 
Pakistan Parkinson's Society , formed 2008 by a patient Mr. Haroon Bashir. This is a patient centered society and not a 
professional society. This has been very successful. They have organized over 50 events, mainly in Karachi but few in other 
cities as well.Pakistan Parkinson's Society is more of a community and patient based society and does not replace a 
professional society aimed at .Please check their website at ;parkinsons.org.pk. Some of their activities:
• PPS in collaboration with Dr. Rana Qayyum have published a patient information booklet in Urdu in 2015 and has
 been distributed to patients
• Held programs for patients in Lahore and Faisalabad under patronage of local physicians but over 95% of activities 
 are restricted to Karachi.
• Dozens of  public awareness seminars  arranged including on World Parkinson’s Day
• Various media presentations on TV, radio to enhance public awareness, dozens of press releases
• Six programs under wellness series held in Jinnah Hospital Karachi for non affording patients
• Patient Support Groups, a successful project, currently meeting on first Thursday of the month and so far over 40 
 sessions has been held. Non affording patients are welcomed
• Support Group in JPMC, AKUH and South City Hospital launched in September 2012.
• In conjunction with AKUH Rehab Department developed a structured exercise program which was well received.
• Additionally PPS also sourced and invited experts on DBS to create awareness 
• PPS from last 4 years have being organizing Parkinson’s Unity Walk with the support of Dr. Mughis Sheerani and The 
 Rehab Center AKUH.
• PPS participated on the Parkinson’s Global Quilt Program (2011) and galvanized members to submit Quilts.
• PPS over 7 years built relationship with the European and US PD association sourcing latest information material 
 consisting of CDs, broachers and information on teleseminars.
• A fall prevention program has been introduced as a test in Jinnah Hospital, Dow College for Physical Therapy and Civil 
 Hospital Karachi. This is focused on non affording patients.
Pakistan's first National Parkinson's and Movement Disorders Conference 
On October 3-4, 2015 Pakistan's first National Parkinson's and Movement Disorders Conference was held at Hotel 
Margala, Islamabad. This was a highly successful meeting with international and national faculty. It was attended by over 
70 neurologists, neurosurgeons and trainees. This was organized by Dr Arsalan Ahmed and there was assistance from Dr 
Jawad Bajwa (an active movement disorders specialist in Saudi Arabia) for the course materials and speakers through the 
International Movement Disorders Society. There was considerable discussion in the months prior to the meeting 
regarding helping the field of  Movement Disorders in Pakistan. It was decided to invite during the meeting interested 
neurologists to determine how the field of Movement Disorders may be developed in Pakistan. This 'strategic' meeting on 
October 3rd was called by Dr Nadir Ali Syed and attended by Dr M. Tariq, Dr Aziz Sonawalla,  Dr. Athar Javed, Dr Arsalan 
Ahmad, Dr Ahsan Numan, Dr Khurram Haq Nawaz, Dr Jawad Bajwa, Dr Danish Bhatti, Dr Asif Bashir, Dr Azhar Saeed, Dr 
Maimoona Siddiqui and a few others,The agenda of the meeting was to determine how best to move forward in the field 
of  movement disorders in Pakistan. The following points emerged during this meeting.
• Parkinson's Disease and other movement disorders in Pakistan require improvement in clinical care, education and 
 research. 
• Although there has been some activity in the field for example the patient based Pakistan Parkinson's Society and 
 good contributions by neurologists across Pakistan but now it is time for a national professional body to be formed, 
 preferably in collaboration with PSN similar to the national headache, stroke or epilepsy societies. This would 
 facilitate education, patient care and research.
• Dr M Tariq suggested making a 2 member committee comprising Dr Nadir Ali Syed and Dr Athar Javed to formulate
 the initial framework of the society 
• The society should be an inclusive body, with recruitment of all interested physicians. 
• There is need to promote local human resource development perhaps through developing fellowship training
 programs, organizing more movement disorders related meetings, use of internet based resources etc. Some 
 participants suggested collaboration with international bodies to facilitate for example brief periods of international 
 exposure at centers of excellence abroad. 
• Several neurologists expressed interest in participating in developing movement disorders in Pakistan
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INTRODUCTION
Epilepsy is a chronic condition in which non-compliance is 
considered to be a significant problem faced during clinical 
treatment. Poor compliance to treatment is one of many 
reasons for pharmacological treatment failure and seizure 
recurrence. Despite all the best intention and efforts on 
the part of the healthcare professionals, those outcomes 
might not be achievable if the patients are non-compliant. 
(1) The behavior of compliance depends on specific clinical 
situation, nature of the illness, and treatment program. 
The effect of recurrent epileptic seizure attacks on the 
patient is far reaching. Poor compliance may lead to status 
epilepticus, as well as unexpected, sudden death. (2) 
Recurrent convulsions can reduce the likelihood of 
eventually curing the disorder. With appropriate treatment 
and lifestyle changes, the majority of patients diagnosed 
with epilepsy will become seizure-free. Compliant 
behaviour can be defined as taking anti-epileptic drugs 
(AEDs) on time and without fail, not manipulating dosages, 
and following the doctor’s advice regarding daily activities. 
(2) Non-compliance is a significant problem in epilepsy 
management. As many as 30 to 50% of persons with 
epilepsy are non-compliant to the extent of interfering with 
their optimal treatment. (2) The effect of non-compliance is 
enormous and may lead to an increase in the number of 
seizures, medical costs and injury to themselves and 
others.(2) The frequency of non-compliance was 19% in the 
outpatient group as reported in one study. (3) Reasons for 
non-compliance are complex and multilayered. Patients 
can accidentally fail to adhere through forgetfulness, 
misunderstanding, or uncertainty about clinician’s 
recommendations, or intentionally due to their own 
expectations of treatment, side-effects, and lifestyle 
choice. (3) In India, a study relating to doctor-patient 
communication and compliance stated that compliance 
improved when patients were satisfied with the 
consultation process and were asked to recall the 
information. Multiple visits to the doctor enhanced 
communication, and thus compliant behaviour. (4) Most of 
studies have attempted either to identify predictors or to 
measure the incidence of non-compliance but there is not 
a validated scale for measuring epilepsy patient 
non-compliance to antiepileptic drugs. This is especially 
true for developing countries including Pakistan. The lack 
of these measurements provides difficulties to assess the 
impact of specific factors in compliance to treatment. 
Services Hospital is the regional hospital in the central 
Punjab and serves a huge population of the country. There 
is scarcity of published data reporting the prevalence of 
epileptic patients with noncompliance of antiepileptic 
drugs. In the present study, we have aimed to determine 
the prevalence of compliance and non-compliance of 
antiepileptic drugs in epileptic patients. 
MATERIALS AND METHODS
The present study was conducted in OPD (Outpatient 
Department) at Services Institute of Medical Sciences and 
Services Hospital, Lahore, Pakistan. This 6-month 
descriptive study was carried out in 2012 and included a 
total of 225 patients who were admitted with the primary 
diagnosis of Epilepsy. Male and female patients aged 
between 10 to 70 years, who had been diagnosed with 
epilepsy at least one year previously, were included. 
Patients having other co-morbidities were excludded from 
this study. The data-collection tools were a questionnaire 
and a structured interview. Patients who were not able to 
respond to an interview were also excluded. For each 
patient detail history was taken including demographic 
information (age, sex, address) and questionnaire was 
asked after taking informed consent by researcher herself. 
All patients were observed for anti-epilepsy drug 
compliance and non-compliance. Patients included in 
study, were treated free of cost. Participants gave written 
informed consent after the purpose of the study had been 
explained to them. The ethics committee of the hospital 
approved the study. 
Statistical Analyses
The descriptive statistical analysis included examinations 
of means, standard deviations, frequencies, ranges, and 
percentages. The statistical packages SPSS (Version 20) 
and MS Excel (MS Office 2010) were used. 
RESULTS
A total of 225 patients fulfilling the inclusion criteria were 
enrolled to measure the frequency of noncompliance of 
antiepileptic drugs in epileptic patients. Age distribution of 
the patients was done which showed that 29.78% 
(n=67) were between 10-30 years, 36% (n=81) 
between 41-55 years and 34.22% (n=77) were between 
56-70 years of age. Average age of the patients was 
46.87+5.23 years (Table 1). 
Table 1. Age distribution of patients included in the study.
Mean and SD: 46.87+5.23 (n= 225)
Gender distribution of the patients showed that 59.6% 
(n=134) were males and 40.4% (n=91) were females 
(Table 2). 
Table 2. Gender distribution of all patients included in this 
study.
Results regarding the frequency of epileptic patients with 
compliance and non-compliance of antiepileptic drugs 
have been shown in Figure 1. Figure shows that out of 
225 patients, 172 patients (76.4%) had compliance of 
antiepileptic drugs. Whereas 53 patients (23.6%) showed 
non-compliance to antiepileptic drugs (Figure 1).
 
Figure 1. Frequency of compliance and non-compliance 
of antiepileptic drugs among epileptic patients.
We also identified the gender distribution of epileptic 
patients with non-compliance of antiepileptic drugs. The 
results have been shown in Table 3 which shows that out 
of 53 cases of non-compliance, 33 cases (62.3%) were 
male and 20 cases (37.7%) were females (Table 3). This 
finding showed that incidence of non-compliance was 
more frequent in males as compared to females.
Table 3. Stratification for noncompliance of antiepileptic 




The sole treatment available for the majority of patients 
with epilepsy is antiepileptic drug (AED) therapy. Research 
has shown that missing or altering antiepileptic drug 
dosages can have adverse reactions, that is, increase the 
chance of seizure recurrence. For instance, Mattson et al. 
reported that over one quarter of seizures occurred at or 
before reports of inadequate medication levels. Failure to 
follow prescribed drug regimens is known to be fairly 
widespread amongst patients with epilepsy: research has 
shown that between 25 and 75% fail to adhere, in 
particular very young or very old patients, and teenagers. 
Given that failing to comply may increase the likelihood of 
hospital admission, there could be a potential savings if 
compliance could be improved. We planned this study to 
determine the most prevalent factors in Pakistan because 
demographic, psychosocial, economic factors, literacy 
rate is different. Non-compliance of antiepileptic drugs in 
epileptic patients leads to recurrent seizures, thus mental 
regression occurs (2); by knowing the frequency of 
non-compliance, we can adopt some strategies to 
over-come this problem to improve levels of compliance 
thereby reducing the risk of unnecessary seizures. In this 
study, frequency of non-compliance of antiepileptic drugs 
in epileptic patients was revealed in 23.56% while 
76.44% had no complaint of non-compliance. The 
findings of the present study regarding frequency of 
non-compliance are in agreement with Hauser et al. (5) 
WHO reported that 19% of the patients had 
non-compliance in the outpatient group.(5) The evidence 
indicates that non-compliance is still common in 
healthcare and no substantial change occurred despite 
the large number of studies attempting to address and 
highlight the problem. In addition, too few studies are 
being done systematically to quantify the impact of 
non-compliance on health and financial outcomes. The 
magnitude of the impact of non-compliance needs to be 
studied in future compliance research due to the potential 
tremendous implication of poor compliance on clinical 
and economic outcomes.
CONCLUSION
We concluded that the frequency of noncompliance of 
antiepileptic drugs among epileptic patients is higher. This 
condition is worsening for males since they showed a 
greater percentage of non-compliance as compared to 
females. This situation needs special attention of the 
physicians while managing epileptic patients.
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Earlier discussions about a professional society relating to movement disorders took place about a decade ago and were 
felt to be a little premature. However PSN nominated Dr Nadir Ali Syed to promote movement disorders related activities. 
Dr Nadir worked with patients to form a patient centered body, the Pakistan Parkinson's Society which has been quite 
active in the last several years. Some of the various Parkinson's and movement disorders related activities are listed in 
appendix A. This is an incomplete list as there is no national professional body dedicated to collate, promote and 
collaborate in movement disorders activities. The intention is to establish a national Parkinson and Movement Disorders 
Society (PMDS), a professional body, drawing upon the precedent of other professional domain specific societies 
previously established focusing on headache, epilepsy, stroke etc. If suitable to PSN the society would work under the 
PSN patronage and collaboration. The society would comprise of interested physicians, ancillary heath care workers, 
students, patients and caregivers in different classes of membership. PMDS may facilitate activities in three major 
areaswith modifications as per input of members. Education and professional development. This includes general 
public awareness, ancillary health care providers (e.g. nurses, rehab personnel), Medical students, general practitioners, 
Neurology trainees, neurologists, Rehabilitation specialists and neurosurgeons. Clinical Service. Promoting Movement 
disorders clinics, developing specialized services relevant to movement disorders. Use of information technology to reach 
out to relatively remote practitioners. Research. Promoting highlighting  and facilitating research. Strategies for achieving 
objectives would evolve with input from members but may include;
• Information technology
• Could include developing a repository of online teaching materials, modules, linkages to other websites etc. 
• Regular conferences, meeting, workshops
• Patient support groups
• Media
• Development of guidelines/protocols
• Collaboration with other national and international bodiese.g. Pakistan Parkinson's Society, a patient based society
 active largely in Karachi
On November 29th at the business meeting of PSN in Lahore it was decided to initiate a national movement disorders 
society aimed at physicians at the March 2016 meeting of PSN. PSN initiatives related to movement disorders. 
Movement disorders related activities in the previous few years - an incomplete compilation but perhaps adequate to 
demonstrate there is activity enough to providescope for a national professional body.
• October 3-4, 2015 Pakistan's first National Parkinson's and Movement Disorders Conference was held at Hotel
 Margala, Islamabad. Organized by Dr Arsalan Ahmed
• Jan 2015, 'National Guidelines for Diagnosis and Management of Parkinson's Disease' published in PJNS,  as a
 collaborative effort of national and international neurologists compiled by Dr Wasay. Subsequently published in a 
 booklet for mass dissemination to GPs. Lead author Dr Nadir Ali Syed
• 28th March 2014 Botox workshop organized as part of PSN meeting by Dr Wasay in Sheraton, Karachi  with 
 international experts including Dr Ronald Pfeiffer, Eric Wolters, and Daniel Truong
• MINDS Symposium- Movement disorders Workshop incorporated. well attended May 17-19, 2009 Muzaffarabad in
 collaboration with GSK. symposium
• Botox Workshops by Dr Nadir Ali Syed in Karachi, Islamabad and Colombo in association with Allergan. Dr Arsalan 
 has organized several botox workshops in Islamabad. 
Pakistan Parkinson's Society , formed 2008 by a patient Mr. Haroon Bashir. This is a patient centered society and not a 
professional society. This has been very successful. They have organized over 50 events, mainly in Karachi but few in other 
cities as well.Pakistan Parkinson's Society is more of a community and patient based society and does not replace a 
professional society aimed at .Please check their website at ;parkinsons.org.pk. Some of their activities:
• PPS in collaboration with Dr. Rana Qayyum have published a patient information booklet in Urdu in 2015 and has
 been distributed to patients
• Held programs for patients in Lahore and Faisalabad under patronage of local physicians but over 95% of activities 
 are restricted to Karachi.
• Dozens of  public awareness seminars  arranged including on World Parkinson’s Day
• Various media presentations on TV, radio to enhance public awareness, dozens of press releases
• Six programs under wellness series held in Jinnah Hospital Karachi for non affording patients
• Patient Support Groups, a successful project, currently meeting on first Thursday of the month and so far over 40 
 sessions has been held. Non affording patients are welcomed
• Support Group in JPMC, AKUH and South City Hospital launched in September 2012.
• In conjunction with AKUH Rehab Department developed a structured exercise program which was well received.
• Additionally PPS also sourced and invited experts on DBS to create awareness 
• PPS from last 4 years have being organizing Parkinson’s Unity Walk with the support of Dr. Mughis Sheerani and The 
 Rehab Center AKUH.
• PPS participated on the Parkinson’s Global Quilt Program (2011) and galvanized members to submit Quilts.
• PPS over 7 years built relationship with the European and US PD association sourcing latest information material 
 consisting of CDs, broachers and information on teleseminars.
• A fall prevention program has been introduced as a test in Jinnah Hospital, Dow College for Physical Therapy and Civil 
 Hospital Karachi. This is focused on non affording patients.
Pakistan's first National Parkinson's and Movement Disorders Conference 
On October 3-4, 2015 Pakistan's first National Parkinson's and Movement Disorders Conference was held at Hotel 
Margala, Islamabad. This was a highly successful meeting with international and national faculty. It was attended by over 
70 neurologists, neurosurgeons and trainees. This was organized by Dr Arsalan Ahmed and there was assistance from Dr 
Jawad Bajwa (an active movement disorders specialist in Saudi Arabia) for the course materials and speakers through the 
International Movement Disorders Society. There was considerable discussion in the months prior to the meeting 
regarding helping the field of  Movement Disorders in Pakistan. It was decided to invite during the meeting interested 
neurologists to determine how the field of Movement Disorders may be developed in Pakistan. This 'strategic' meeting on 
October 3rd was called by Dr Nadir Ali Syed and attended by Dr M. Tariq, Dr Aziz Sonawalla,  Dr. Athar Javed, Dr Arsalan 
Ahmad, Dr Ahsan Numan, Dr Khurram Haq Nawaz, Dr Jawad Bajwa, Dr Danish Bhatti, Dr Asif Bashir, Dr Azhar Saeed, Dr 
Maimoona Siddiqui and a few others,The agenda of the meeting was to determine how best to move forward in the field 
of  movement disorders in Pakistan. The following points emerged during this meeting.
• Parkinson's Disease and other movement disorders in Pakistan require improvement in clinical care, education and 
 research. 
• Although there has been some activity in the field for example the patient based Pakistan Parkinson's Society and 
 good contributions by neurologists across Pakistan but now it is time for a national professional body to be formed, 
 preferably in collaboration with PSN similar to the national headache, stroke or epilepsy societies. This would 
 facilitate education, patient care and research.
• Dr M Tariq suggested making a 2 member committee comprising Dr Nadir Ali Syed and Dr Athar Javed to formulate
 the initial framework of the society 
• The society should be an inclusive body, with recruitment of all interested physicians. 
• There is need to promote local human resource development perhaps through developing fellowship training
 programs, organizing more movement disorders related meetings, use of internet based resources etc. Some 
 participants suggested collaboration with international bodies to facilitate for example brief periods of international 
 exposure at centers of excellence abroad. 
• Several neurologists expressed interest in participating in developing movement disorders in Pakistan
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INTRODUCTION
Epilepsy is a chronic condition in which non-compliance is 
considered to be a significant problem faced during clinical 
treatment. Poor compliance to treatment is one of many 
reasons for pharmacological treatment failure and seizure 
recurrence. Despite all the best intention and efforts on 
the part of the healthcare professionals, those outcomes 
might not be achievable if the patients are non-compliant. 
(1) The behavior of compliance depends on specific clinical 
situation, nature of the illness, and treatment program. 
The effect of recurrent epileptic seizure attacks on the 
patient is far reaching. Poor compliance may lead to status 
epilepticus, as well as unexpected, sudden death. (2) 
Recurrent convulsions can reduce the likelihood of 
eventually curing the disorder. With appropriate treatment 
and lifestyle changes, the majority of patients diagnosed 
with epilepsy will become seizure-free. Compliant 
behaviour can be defined as taking anti-epileptic drugs 
(AEDs) on time and without fail, not manipulating dosages, 
and following the doctor’s advice regarding daily activities. 
(2) Non-compliance is a significant problem in epilepsy 
management. As many as 30 to 50% of persons with 
epilepsy are non-compliant to the extent of interfering with 
their optimal treatment. (2) The effect of non-compliance is 
enormous and may lead to an increase in the number of 
seizures, medical costs and injury to themselves and 
others.(2) The frequency of non-compliance was 19% in the 
outpatient group as reported in one study. (3) Reasons for 
non-compliance are complex and multilayered. Patients 
can accidentally fail to adhere through forgetfulness, 
misunderstanding, or uncertainty about clinician’s 
recommendations, or intentionally due to their own 
expectations of treatment, side-effects, and lifestyle 
choice. (3) In India, a study relating to doctor-patient 
communication and compliance stated that compliance 
improved when patients were satisfied with the 
consultation process and were asked to recall the 
information. Multiple visits to the doctor enhanced 
communication, and thus compliant behaviour. (4) Most of 
studies have attempted either to identify predictors or to 
measure the incidence of non-compliance but there is not 
a validated scale for measuring epilepsy patient 
non-compliance to antiepileptic drugs. This is especially 
true for developing countries including Pakistan. The lack 
of these measurements provides difficulties to assess the 
impact of specific factors in compliance to treatment. 
Services Hospital is the regional hospital in the central 
Punjab and serves a huge population of the country. There 
is scarcity of published data reporting the prevalence of 
epileptic patients with noncompliance of antiepileptic 
drugs. In the present study, we have aimed to determine 
the prevalence of compliance and non-compliance of 
antiepileptic drugs in epileptic patients. 
MATERIALS AND METHODS
The present study was conducted in OPD (Outpatient 
Department) at Services Institute of Medical Sciences and 
Services Hospital, Lahore, Pakistan. This 6-month 
descriptive study was carried out in 2012 and included a 
total of 225 patients who were admitted with the primary 
diagnosis of Epilepsy. Male and female patients aged 
between 10 to 70 years, who had been diagnosed with 
epilepsy at least one year previously, were included. 
Patients having other co-morbidities were excludded from 
this study. The data-collection tools were a questionnaire 
and a structured interview. Patients who were not able to 
respond to an interview were also excluded. For each 
patient detail history was taken including demographic 
information (age, sex, address) and questionnaire was 
asked after taking informed consent by researcher herself. 
All patients were observed for anti-epilepsy drug 
compliance and non-compliance. Patients included in 
study, were treated free of cost. Participants gave written 
informed consent after the purpose of the study had been 
explained to them. The ethics committee of the hospital 
approved the study. 
Statistical Analyses
The descriptive statistical analysis included examinations 
of means, standard deviations, frequencies, ranges, and 
percentages. The statistical packages SPSS (Version 20) 
and MS Excel (MS Office 2010) were used. 
RESULTS
A total of 225 patients fulfilling the inclusion criteria were 
enrolled to measure the frequency of noncompliance of 
antiepileptic drugs in epileptic patients. Age distribution of 
the patients was done which showed that 29.78% 
(n=67) were between 10-30 years, 36% (n=81) 
between 41-55 years and 34.22% (n=77) were between 
56-70 years of age. Average age of the patients was 
46.87+5.23 years (Table 1). 
Table 1. Age distribution of patients included in the study.
Mean and SD: 46.87+5.23 (n= 225)
Gender distribution of the patients showed that 59.6% 
(n=134) were males and 40.4% (n=91) were females 
(Table 2). 
Table 2. Gender distribution of all patients included in this 
study.
Results regarding the frequency of epileptic patients with 
compliance and non-compliance of antiepileptic drugs 
have been shown in Figure 1. Figure shows that out of 
225 patients, 172 patients (76.4%) had compliance of 
antiepileptic drugs. Whereas 53 patients (23.6%) showed 
non-compliance to antiepileptic drugs (Figure 1).
 
Figure 1. Frequency of compliance and non-compliance 
of antiepileptic drugs among epileptic patients.
We also identified the gender distribution of epileptic 
patients with non-compliance of antiepileptic drugs. The 
results have been shown in Table 3 which shows that out 
of 53 cases of non-compliance, 33 cases (62.3%) were 
male and 20 cases (37.7%) were females (Table 3). This 
finding showed that incidence of non-compliance was 
more frequent in males as compared to females.
Table 3. Stratification for noncompliance of antiepileptic 




The sole treatment available for the majority of patients 
with epilepsy is antiepileptic drug (AED) therapy. Research 
has shown that missing or altering antiepileptic drug 
dosages can have adverse reactions, that is, increase the 
chance of seizure recurrence. For instance, Mattson et al. 
reported that over one quarter of seizures occurred at or 
before reports of inadequate medication levels. Failure to 
follow prescribed drug regimens is known to be fairly 
widespread amongst patients with epilepsy: research has 
shown that between 25 and 75% fail to adhere, in 
particular very young or very old patients, and teenagers. 
Given that failing to comply may increase the likelihood of 
hospital admission, there could be a potential savings if 
compliance could be improved. We planned this study to 
determine the most prevalent factors in Pakistan because 
demographic, psychosocial, economic factors, literacy 
rate is different. Non-compliance of antiepileptic drugs in 
epileptic patients leads to recurrent seizures, thus mental 
regression occurs (2); by knowing the frequency of 
non-compliance, we can adopt some strategies to 
over-come this problem to improve levels of compliance 
thereby reducing the risk of unnecessary seizures. In this 
study, frequency of non-compliance of antiepileptic drugs 
in epileptic patients was revealed in 23.56% while 
76.44% had no complaint of non-compliance. The 
findings of the present study regarding frequency of 
non-compliance are in agreement with Hauser et al. (5) 
WHO reported that 19% of the patients had 
non-compliance in the outpatient group.(5) The evidence 
indicates that non-compliance is still common in 
healthcare and no substantial change occurred despite 
the large number of studies attempting to address and 
highlight the problem. In addition, too few studies are 
being done systematically to quantify the impact of 
non-compliance on health and financial outcomes. The 
magnitude of the impact of non-compliance needs to be 
studied in future compliance research due to the potential 
tremendous implication of poor compliance on clinical 
and economic outcomes.
CONCLUSION
We concluded that the frequency of noncompliance of 
antiepileptic drugs among epileptic patients is higher. This 
condition is worsening for males since they showed a 
greater percentage of non-compliance as compared to 
females. This situation needs special attention of the 
physicians while managing epileptic patients.
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